Explore our research reports and policy briefs, designed to explain key findings of our work clearly and provide recommendations for government, community organisations and policymakers alike.
Collaborative approach in primary care increases access to hepatitis C treatment in a regional area
Implementation of a remote consultation pathway facilitates interaction between general practitioner...
POLICY BRIEF
Identifying high-priority regions for hepatitis C treatment in Australia
Targeted interventions are needed to increase hepatitis C treatment uptake in non- metropolitan area...
POLICY BRIEF
Eliminating hepatitis C virus among HIV-positive men
Routine testing and prompt treatment uptake can significantly reduce hepatitis C prevalence among HI...
POLICY BRIEF
ST KILDA 24-HOUR NSP EVALUATION.
The Salvation Army commissioned the Burnet Institute to gather data on its 24-hour needle and syring...
RESEARCH REPORT
Elimination of hepatitis C requires a comprehensive approach to care
Universal access to hepatitis C medication alone is insufficient to eliminate hepatitis C as a publi...
POLICY BRIEF
Resources are required to support management of hepatitis C in general practice
A Burnet Institute survey undertaken in 2016 showed that although many general practitioners are int...
POLICY BRIEF
Needle sharing remains the major risk factor for hepatitis C infection
Hepatitis C incidence appears to be decreasing, but in a cohort of people who inject drugs in Melbou...
POLICY BRIEF
Psychological distress in people who inject drugs
People who inject drugs experience high levels of psychological distress and recent assault, intenti...
POLICY BRIEF
Evidence supports community-based hepatitis C care
A systematic review conducted in 2015 demonstrated that – compared to tertiary- based hepatitis C ca...
POLICY BRIEF
Achievable and cost-effective elimination targets in Australia
Reaching the WHO hepatitis C elimination targets in Australia is cost-effective and can be achieved ...
POLICY BRIEF
Treating hepatitis C saves lives and is cost-effective
Treating people who inject drugs for hepatitis C with new therapies is cost-effective and could prev...
POLICY BRIEF
The benefits of a hepatitis C vaccine
Even a partially effective hepatitis C vaccine could effectively complement existing treatments to r...
POLICY BRIEF
Overview of viral hepatitis treatment research in China. (WHO Report).
China is confronted with a significant challenge in managing a substantial population afflicted with...
RESEARCH ARTICLE
Understanding and describing Australian illicit drug markets: Drug price variations and associated changes in a cohort of people who inject drugs.
This project was undertaken to provide a detailed understanding of the interface between the price o...
RESEARCH REPORT
The importance of injecting networks
Significant and ongoing Burnet Institute research has provided important insights into the social ne...
POLICY BRIEF
Patterns of drug preference and use among people who inject drugs in Melbourne, Australia.
Background: Understanding of substitution patterns in drug using careers is limited. Between 2009 an...
RESEARCH REPORT
Predictors of spontaneous hepatitis C clearance after reinfection
Gender and genetics could identify people who are more likely to eliminate hepatitis C after reinfec...
POLICY BRIEF
Optimising opportunities to provide harm reduction counselling
Hepatitis C testing in people who inject drugs should be combined with harm reduction counselling to...
POLICY BRIEF
Investigating the impact of climate on dengue disease transmission in urban Colombo: A Fuzzy logic model, Proceedings of the 4th Annual International Conference on Computational Mathematics, Computational Geometry & Statistics
RESEARCH REPORT
Using social networks to reduce hepatitis C prevalence
Targeting social networks with a ‘treat your friends’ approach is a feasible, practical and effectiv...